Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice

Cardiovascular Pathology

Volumn 18, Issue 2, 2009, Pages 100-109

  Cipollone, Daria ^a,c   Carsetti, Rita ^b   Tagliani, Angela ^c   Rosado, Maria Manuela ^b   Borgiani, Paola ^a   Novelli, Giuseppe ^a   D'Amati, Giulia ^d   Fumagalli, Lorenzo ^c   Marino, Bruno ^c   Businaro, Rita ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

BMS 189453; Congenital anomalies; Folic acid; Methionine; Retinoic acid

Indexed keywords

FOLIC ACID; METHIONINE; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL TERATOGENESIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FETUS; HISTOPATHOLOGY; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; THYMUS DISEASE;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ANIMALS; ANIMALS, OUTBRED STRAINS; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; HEART DEFECTS, CONGENITAL; METHIONINE; MICE; NEURAL TUBE DEFECTS; PREGNANCY; RETINOIDS; TERATOGENS; THYMUS GLAND;

EID: 61349100859     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.02.007     Document Type: Article

References (39)

1. Hoffman J.I. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 16 (1995) 103-113
2. Hoffman J.I., and Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 39 (2002) 1890-1900
3. Gruber P.J., and Epstein J.A. Development gone awry: congenital heart disease. Circ Res 94 (2004) 273-283
4. Costell M., Carmona R., Gustafsson E., Gonzalez-Iriarte M., Fassler R., and Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 91 (2002) 158-164
5. Zhu H., Wlodarczyk B.J., Scott M., Yu W., Merriweather M., Gelineau-van Waes J., Schwartz R.J., and Finnell R.H. Cardiovascular abnormalities in Folr1 knockout mice and folate rescue. Birth Defects Res A Clin Mol Teratol 79 (2007) 257-268
6. Yasui H., Nakazawa M., Morishima M., Miyagawa-Tomita S., and Momma K. Morphological observations on the pathogenetic process of transposition of the great arteries induced by retinoic acid in mice. Circulation 91 (1995) 2478-2486
7. Cipollone D., Amati F., Carsetti R., Placidi S., Biancolella M., D'Amati G., Novelli G., Siracusa G., and Marino B. A multiple retinoic acid antagonist induces conotruncal anomalies, including transposition of the great arteries, in mice. Cardiovasc Pathol 15 (2006) 194-202
8. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338 (1991) 131-137
9. Berry R.J., Li Z., Erickson J.D., Li S., Moore C.A., Wang H., Mulinare J., Zhao P., Wong L.Y., Gindler J., Hong S.X., and Correa A. Prevention of neural-tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341 (1999) 1485-1490 Erratum in: N Engl J Med 1999;341:1864
10. Hernandez-Diaz S., Werler M.M., Walker A.M., and Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343 (2000) 1608-1614
11. Botto L.D., Lisi A., Bower C., Canfield M.A., Dattani N., De Vigan C., De Walle H., Erickson D.J., Halliday J., Irgens L.M., Lowry R.B., McDonnell R., Metneki J., Poetzsch S., Ritvanen A., Robert-Gnansia E., Siffel C., Stoll C., and Mastroiacovo P. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol 76 (2006) 693-705
12. Shaw G.M., O'Malley C.D., Wasserman C.R., Tolarova M.M., and Lammer E.J. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59 (1995) 536-545
13. Botto L.D., Mulinare J., Erickson J.D., Botto L.D., Mulinare J., and Erickson J.D. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet A 121 (2003) 95-101
14. Czeizel A.E., Toth M., and Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 53 (1996) 345-351
15. Shaw G.M., Lammer E.J., Wasserman C.R., O'Malley C.D., and Tolarova M.M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346 (1995) 393-396
16. Werler M.M., Hayes C., Louik C., Shapiro S., and Mitchell A.A. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150 (1999) 675-682
17. Kang S.S., Wong P.W., and Norusis M. Homocysteinemia due to folate deficiency. Metabolism 36 (1987) 458-462
18. Steegers-Theunissen R.P., Boers G.H., Trijbels F.J., and Eskes T.K. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 324 (1991) 199-200
19. Steegers-Theunissen R.P., Boers G.H., Blom H.J., Nijhuis J.G., Thomas C.M., Borm G.F., and Eskes T.K. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172 (1995) 1436-1441
20. Kapusta L., Haagmans M.L., Steegers E.A., Cuypers M.H., Blom H.J., and Eskes T.K. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135 (1999) 773-774
21. Lee R.Y., Luo J., Evans R.M., Giguere V., and Sucov H.M. Compartment-selective sensitivity of cardiovascular morphogenesis to combinations of retinoic acid receptor gene mutations. Circ Res 80 (1997) 757-764
22. Reynolds P.R., Schaalje G.B., and Seegmiller R.E. Combination therapy with folic acid and methionine in the prevention of retinoic acid-induced cleft palate in mice. Birth Defects Res A Clin Mol Teratol 67 (2003) 168-173
23. Wendling O., Dennefeld C., Chambon P., and Mark M. Retinoid signaling is essential for patterning the endoderm of the third and fourth pharyngeal arches. Development 127 (2000) 1553-1562
24. Lau E.C., and Li Z.Q. Protection of mice from teratogen-induced cleft palate by exogenous methionine. Proc Soc Exp Biol Med 209 (1995) 141-145
25. Hook E.B. Folic acid: abortifacient or pseudoabortifacient?. Am J Med Genet. 92 (2000) 301-302
26. Reamon-Buettner S.M., and Borlak J. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation. Reprod Toxicol. 24 (2007) 20-30
27. George L., Mills J.L., Johansson A.L., Nordmark A., Olander B., Granath F., and Cnattingius S. Plasma folate levels and risk of spontaneous abortion. JAMA 288 (2002) 1867-1873
28. Verkleij-Hagoort A., Bliek J., Sayed-Tabatabaei F., Ursem N., Steegers E., and Steegers-Theunissen R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am J Med Genet A 143 (2007) 952-960
29. Padmanabhan R., Shafiullah M., Benedict S., and Nagelkerke N. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos. Eur J Nutr 45 (2006) 311-319
30. Afman L.A., Blom H.J., Van der Put N.M., and Van Straaten H.W. Homocysteine interference in neurulation: a chick embryo model. Birth Defects Res A Clin Mol Teratol 67 (2003) 421-428
31. Boot M.J., Steegers-Theunissen R.P., Poelmann R.E., van Iperen L., and Gittenberger-de Groot A.C. Homocysteine induces endothelial cell detachment and vessel wall thickening during chick embryonic development. Circ Res 94 (2004) 542-549
32. Boot M.J., Steegers-Theunissen R.P., Poelmann R.E., van Iperen L., and Gittenberger-de Groot A.C. Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res 64 (2004) 365-373
33. Rosendahl A., Speletas M., Leandersson K., Ivars F., and Sideras P. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoiesis. Int Immunol 15 (2003) 1401-1414
34. + stage in Bcl11b-/- mice. Biochem Biophys Res Commun 328 (2005) 545-549
35. Kokkinakis D.M., Liu X., and Neuner R.D. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther 4 (2005) 1338-1348
36. Portugal V., Garcia-Alonso I., Barcelo P., and Mendez J. Effect of allopurinol, folinic acid, SOD and cyclosporine A on ischemic liver regeneration. Eur Surg Res 27 (1995) 69-76
37. Xiao S., Hansen D.K., Horsley E.T., Tang Y.S., Khan R.A., Stabler S.P., Jayaram H.N., and Antony A.C. Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues. Birth Defects Res A Clin Mol Teratol 73 (2005) 6-28
38. Singh R., Fouladi-Nashta A.A., Li D., Halliday N., Barrett D.A., and Sinclair K.D. Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. J Cell Biochem 99 (2006) 146-155
39. Mattson M.P. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev 2 (2003) 329-342